Anthem Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	3,161	1,839	3,422	3,418	362.82
Short-Term Investments	-	-	-	4,929	2,691	-
Trading Asset Securities	-	4,161	4,591	-	-	2,091
Cash & Short-Term Investments	7,323	7,323	6,429	8,351	6,109	2,454
Cash Growth	13.90%	13.90%	-23.01%	36.70%	148.94%	-
Accounts Receivable	-	4,504	4,904	2,741	3,262	2,546
Other Receivables	-	95.15	1.96	12.15	73.23	23.47
Receivables	-	4,599	4,906	2,753	3,335	2,570
Inventory	-	3,404	2,113	1,294	582.3	350.63
Prepaid Expenses	-	2.14	31.67	19.43	25.04	17.68
Restricted Cash	-	-	-	-	-	40.02
Other Current Assets	-	2,039	1,335	814.18	881.44	725.69
Total Current Assets	-	17,367	14,816	13,232	10,933	6,158
Property, Plant & Equipment	-	9,981	8,210	6,039	4,759	3,737
Long-Term Investments	-	169.28	125.53	61.6	36.96	-
Other Intangible Assets	-	38.71	62.43	90.89	68.99	64.18
Long-Term Accounts Receivable	-	31.12	31.08	31.08	31.12	31.28
Long-Term Deferred Tax Assets	-	179.47	413.95	249.08	159.38	138.7
Other Long-Term Assets	-	253.87	249.73	370.15	127.81	136.9
Total Assets	-	28,076	23,981	20,145	16,189	10,338
Accounts Payable	-	1,101	1,007	719.41	648.41	769.25
Accrued Expenses	-	252.29	308.02	249.82	245.63	267.01
Short-Term Debt	-	429.53	817.96	87.46	274.93	213.84
Current Portion of Long-Term Debt	-	189.74	390.71	201.3	11.5	577.92
Current Portion of Leases	-	15.06	16.85	3.22	21.22	22.44
Current Income Taxes Payable	-	230.27	64.11	58.83	193.89	256.99
Current Unearned Revenue	-	-	-	3.85	-	8.23
Other Current Liabilities	-	1,045	781.21	314.81	866.29	734.14
Total Current Liabilities	-	3,262	3,386	1,639	2,262	2,850
Long-Term Debt	-	470.28	1,117	961.88	245.8	174.64
Long-Term Leases	-	28.56	43.06	7.64	24.39	34.88
Long-Term Unearned Revenue	-	9.35	11.69	14.18	16.64	19.02
Other Long-Term Liabilities	-	162.81	137.21	81.89	57.99	197.33
Total Liabilities	-	3,977	4,735	2,738	2,639	3,324
Common Stock	-	1,118	1,118	1,141	87.76	84.85
Additional Paid-In Capital	-	1,252	1,252	2,719	2,700	228.1
Retained Earnings	-	21,392	16,879	13,570	10,726	6,658
Comprehensive Income & Other	-	336.79	-2.72	-23.05	35.82	44.15
Shareholders' Equity	24,099	24,099	19,247	17,407	13,550	7,015
Total Liabilities & Equity	-	28,076	23,981	20,145	16,189	10,338
Total Debt	1,133	1,133	2,385	1,262	577.84	1,024
Net Cash (Debt)	6,190	6,190	4,044	7,090	5,531	1,430
Net Cash Growth	53.05%	53.05%	-42.96%	28.17%	286.71%	-
Net Cash Per Share	11.02	11.02	7.13	12.43	9.70	2.62
Filing Date Shares Outstanding	558.81	561.61	559.08	570.49	570.46	546.78
Total Common Shares Outstanding	558.81	559.08	559.08	570.49	570.46	546.78
Working Capital	-	14,105	11,429	11,593	8,671	3,308
Book Value Per Share	43.10	43.10	34.43	30.51	23.75	12.83
Tangible Book Value	24,060	24,060	19,184	17,316	13,481	6,950
Tangible Book Value Per Share	43.04	43.04	34.31	30.35	23.63	12.71
Land	-	836.13	836.13	836.13	836.13	836.13
Buildings	-	3,239	2,012	1,579	1,304	1,304
Machinery	-	8,595	6,761	6,137	4,632	4,439
Construction In Progress	-	2,969	3,447	1,641	1,538	186.8

Source: S&P Global Market Intelligence. Standard template. Financial Sources.